Gilead Sciences (Uzbek Wikipedia)

Analysis of information sources in references of the Wikipedia article "Gilead Sciences" in Uzbek language version.

refsWebsite

Global rank Uzbek rank

16nih.gov

4^th place

7^th place

13web.archive.org

1^st place

13gilead.com

low place

7nytimes.com

7^th place

26^th place

6washingtonpost.com

34^th place

120^th place

6reuters.com

49^th place

94^th place

6doi.org

2^nd place

3^rd place

5fda.gov

447^th place

745^th place

4wsj.com

79^th place

146^th place

4biospace.com

low place

8,313^th place

4bloomberg.com

99^th place

134^th place

3fiercepharma.com

low place

3forbes.com

54^th place

65^th place

3businesswire.com

615^th place

1,283^rd place

3seekingalpha.com

5,344^th place

low place

3latimes.com

22^nd place

132^nd place

2sec.gov

572^nd place

451^st place

2google.com

163^rd place

215^th place

2worldcat.org

5^th place

10^th place

2bizjournals.com

407^th place

663^rd place

2genengnews.com

low place

6,935^th place

2barrons.com

2,737^th place

1,041^st place

2nbcnews.com

137^th place

479^th place

2npr.org

92^nd place

368^th place

1bloomberglaw.com

5,670^th place

low place

1sfgate.com

166^th place

1,336^th place

1books.google.com

3^rd place

4^th place

1wustl.edu

3,160^th place

3,426^th place

1scribd.com

482^nd place

176^th place

1fundinguniverse.com

1,333^rd place

1,087^th place

1nobelprize.org

301^st place

69^th place

1ktvq.com

low place

1healio.com

low place

1pharmatimes.com

low place

1outsourcing-pharma.com

low place

1independent.co.uk

36^th place

137^th place

1clinicaltrials.gov

5,225^th place

6,641^st place

1fortune.com

433^rd place

1,189^th place

1cnbc.com

220^th place

456^th place

1archive.today

14^th place

37^th place

1msn.com

117^th place

278^th place

1yahoo.com

38^th place

100^th place

1parentherald.com

low place

1smh.com.au

132^nd place

1,042^nd place

1streetinsider.com

low place

1fool.com

4,183^rd place

6,524^th place

1macrotrends.net

5,641^st place

7,038^th place

1investors.com

low place

1doctorsoftheworld.org

low place

1chicagotribune.com

95^th place

669^th place

1policymed.com

low place

1ft.com

210^th place

424^th place

1caravanmagazine.in

4,487^th place

low place

1statnews.com

8,771^st place

low place

1arizonalawreview.org

low place

1thetimes.co.uk

170^th place

922^nd place

1msf.org

low place

1thepharmaletter.com

low place

1europa.eu

68^th place

50^th place

1canada.ca

1,712^th place

2,197^th place

archive.today

Gilead Sciences (2011-yil 22-fevral). „Gilead Sciences to Acquire Calistoga Pharmaceuticals for $375 Million; Deal Adds Pipeline Candidates in Oncology and Inflammation“. Press-reliz. 9-iyul 2012-yilda asl nusxadan arxivlandi. Qaraldi: 2011-yil 22-fevral.

arizonalawreview.org

Blair-Stanek, Andrew (2016). „Just Compensation as Transfer Prices“. Arizona Law Review. 58-jild, № 4. 1093–94-bet. Qaraldi: January 4, 2022.

barrons.com

blogs.barrons.com

„Stocks to Watch“. Barrons (2014-yil 2-yanvar).
Ben Levisohn. „Gilead Sciences: Is an Incyte Deal 'Reasonable'?“. Barron's (2017-yil 13-mart).

biospace.com

bizjournals.com

Leuty, Ron. „Gilead breaking ground on 1st part of massive campus rebuild in Foster City“. San Francisco Business Journal. American City Business Journals (2011-yil 19-oktyabr). Qaraldi: 2020-yil 21-mart.
Leuty, Ron. „Pharmacy chains sue Gilead for allegedly blocking lower-cost generic HIV drugs“. San Francisco Business Times (2021-yil 23-sentyabr). Qaraldi: 2021-yil 27-sentyabr.

bloomberg.com

„AstraZeneca Ponders a Huge $240 Billion Gilead Gamble“. Bloomberg.com (2020-yil 7-iyun). Qaraldi: 2020-yil 7-sentyabr.
„AstraZeneca Approaches Gilead About Potential Merger“. Bloomberg (2020-yil 7-iyun). Qaraldi: 2020-yil 7-sentyabr.
Ketaki Gokhale. „The same pill that cost $1,000 in the U.S. sold for $4 in India“. Bloomberg (2015-yil 28-dekabr).
Kocieniewski, David. „Gilead Seen Cutting Taxes by $10 Billion as Pricey Drug Took Off“. Bloomberg (2016-yil 13-iyul). Qaraldi: 2022-yil 4-yanvar.

bloomberglaw.com

news.bloomberglaw.com

„Senate Report Criticizes Gilead's Pricing Strategy for Sovaldi“ (en). news.bloomberglaw.com (2015-yil 2-dekabr). Qaraldi: 2021-yil 19-sentyabr.

books.google.com

Boslaugh, Sarah E.. The Sage Encyclopedia of Pharmacology and Society. Sage Publications, 2015 — 657 bet. ISBN 978-1-4833-4999-2.

businesswire.com

Bristol-Myers Squibb and Gilead Sciences (2006-yil 12-iyul). „U.S. Food and Drug Administration (FDA) Approves Atripla (efavirenz 600 mg/ emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen For Adults With HIV-1 Infection“. Press-reliz. Qaraldi: 2020-yil 12-iyul.
(2020-yil 7-aprel). „Gilead Completes Acquisition of Forty Seven, Inc.“. Press-reliz. Qaraldi: 2020-yil 11-aprel.
„Gilead Lawsuits: 41 HIV and PrEP Patients File California Personal Injury Case Over Gilead's TDF-Based Drugs“. Business Wire (2019-yil 11-aprel). Qaraldi: 2019-yil 7-dekabr.

canada.ca

„COVID-19 Treatments“. Government of Canada (2022-yil 17-yanvar). Qaraldi: 2022-yil 25-yanvar.

caravanmagazine.in

Gahlot. „How big pharma and the Indian government are letting millions of patients down“. The Caravan. Qaraldi: 2019-yil 25-iyul.

chicagotribune.com

Gokhale, Ketaki. „The same pill that costs $1,000 in the U.S. sells for $4 in India“. chicagotribune.com. Qaraldi: 2021-yil 19-sentyabr.

clinicaltrials.gov

„ClinicalTrials.gov – Information on Clinical Trials and Human Research Studies: Darusentan“. Qaraldi: 2007-yil 18-avgust.

cnbc.com

„Fortune 100 Fastest-Growing Companies“. www.cnbc.com (2009-yil 17-avgust). Qaraldi: 2020-yil 13-aprel.

doctorsoftheworld.org

Waldman. „Gilead's HCV drug sofosbuvir approved by the FDA but accessible for how many?“. Doctors of the World. 2014-yil 26-fevralda asl nusxadan arxivlangan. Qaraldi: 2014-yil 22-fevral.

doi.org

„Ledipasvir/Sofosbuvir: a review of its use in chronic hepatitis C“. Drugs. 75-jild, № 6. 2015. 675–85-bet. doi:10.1007/s40265-015-0381-2. PMID 25837989.
Tourret, Jérôme; Deray, Gilbert; Isnard-Bagnis, Corinne (2013). „Tenofovir Effect on the Kidneys of HIV-Infected Patients: A Double-Edged Sword?“. Journal of the American Society of Nephrology. 24-jild, № 10. 1519–1527-bet. doi:10.1681/ASN.2012080857. PMC 3785270. PMID 24052632.
Walensky, Rochelle P.; Horn, Tim; McCann, Nicole C.; Freedberg, Kenneth A.; Paltiel, A. David (May 5, 2020). „Comparative Pricing of Branded Tenofovir Alafenamide–Emtricitabine Relative to Generic Tenofovir Disoproxil Fumarate–Emtricitabine for HIV Preexposure Prophylaxis: A Cost-Effectiveness Analysis“. Annals of Internal Medicine. 172-jild, № 9. 583–590-bet. doi:10.7326/m19-3478. PMC 7217721. PMID 32150602.
Rizk, John G.; Forthal, Donald N.; Kalantar-Zadeh, Kamyar; Mehra, Mandeep R.; Lavie, Carl J.; Rizk, Youssef; Pfeiffer, JoAnn P.; Lewin, John C. (2021). „Expanded Access Programs, compassionate drug use, and Emergency Use Authorizations during the COVID-19 pandemic“. Drug Discovery Today. 26-jild, № 2. 593–603-bet. doi:10.1016/j.drudis.2020.11.025. ISSN 1359-6446. PMC 7694556. PMID 33253920.
„A living WHO guideline on drugs for covid-19“. BMJ. 370-jild. September 2020. m3379-bet. doi:10.1136/bmj.m3379. PMID 32887691.
„Remdesivir for the treatment of patients in hospital with COVID-19 in Canada: a randomized controlled trial“. Canadian Medical Association Journal. 194-jild, № 7. January 2022. E242–E251-bet. doi:10.1503/cmaj.211698. PMC 8863204. PMID 35045989.

europa.eu

ema.europa.eu

„Veklury“. European Medicines Agency (2021-yil 22-dekabr). Qaraldi: 2022-yil 25-yanvar.

fda.gov

(2019-yil 1-iyul). „FDA encourages ongoing education of HIV PrEP treatment“. Press-reliz. Qaraldi: 2020-yil 12-iyul.
„FDA Approves First Treatment for COVID-19“. US Food and Drug Administration (2020-yil 22-oktyabr). Qaraldi: 2022-yil 27-yanvar.
„FDA Takes Actions to Expand Use of Treatment for Outpatients with Mild-to-Moderate COVID-19“. US Food and Drug Administration (2022-yil 21-yanvar). Qaraldi: 2022-yil 26-yanvar.

accessdata.fda.gov

„Drug Approval Package: Truvada (Emtricitabine and Tenofovir Disoproxil Fumarate) NDA #021752“. U.S. Food and Drug Administration (2006-yil 31-yanvar). Qaraldi: 2020-yil 12-iyul.
„Remdesivir Orphan Drug Designations and Approvals“. U.S. Food and Drug Administration (FDA). Qaraldi: 2020-yil 29-iyun.

fiercepharma.com

Stanton. „Activists pounce on $1,000-a-day price for Gilead's hep C wonder drug, Sovaldi“. FiercePharma. 2014-yil 18-fevralda asl nusxadan arxivlangan. Qaraldi: 2014-yil 22-fevral.
„Growth-hungry Gilead finally pivots from flagging hep C with $12B Kite buy“. fiercepharma.com (2017-yil 28-avgust). Qaraldi: 2017-yil 29-avgust.
Kevin Dunleavy. „Resurgent Veklury delivers Gilead $1.9B in sales and an earnings surprise“. Fierce Pharma (2021-yil 29-oktyabr). Qaraldi: 2022-yil 25-yanvar.

fool.com

Michael Douglass. „I Was Wrong About Gilead Sciences“. The Motley Fool (2017-yil 9-mart).

forbes.com

Moukheiber, Kerry A. Dolan Zina. „The Golden Age of Antiviral Drugs“. Forbes. Qaraldi: 2017-yil 14-dekabr.
Moukheiber, Zina; Dolan, Kerry A.. „The Golden Age of Antiviral Drugs“. Forbes (2003-yil 27-oktyabr).
„Grading Pharma in 2013“. Forbes (2013-yil 31-dekabr).

fortune.com

archive.fortune.com

„Fortune 100 Fastest-Growing Companies 2009“. Fortune. Qaraldi: 2020-yil 13-aprel.

ft.com

Kazmin, Amy. „Pharma combats diversion of cheap drugs“. Financial Times (2015-yil 12-aprel). Qaraldi: 2021-yil 27-sentyabr.

fundinguniverse.com

„History of Gilead Sciences, Inc. – FundingUniverse“. fundinguniverse.com.

genengnews.com

„Gilead to Acquire Phenex's FXR Program for Up-to-$470M“. Genetic Engineering and Biotechnology News: GEN.
„Gilead Boosts Cancer Pipeline With $65M EpiTherapeutics Buy“. Genetic Engineering and Biotechnology News: GEN (2015-yil 6-may).

gilead.com

Gilead Sciences and Bristol-Myers Squibb (2006-yil 12-iyul). „U.S. Food And Drug Administration (FDA) Approves Atripla“. Press-reliz. 15-noyabr 2008-yilda asl nusxadan arxivlandi. Qaraldi: 2007-yil 15-dekabr.
Gilead Sciences (2006-yil 3-noyabr). „Gilead Sciences Completes Acquisition of Raylo Chemicals Inc.“. Press-reliz. 16-yanvar 2013-yilda asl nusxadan arxivlandi. Qaraldi: 2007-yil 7-iyun.
Gilead Sciences (2007-yil 15-avgust). „Parion Sciences and Gilead Sciences Sign Agreement to Advance Drug Candidates for Pulmonary Disease“. Press-reliz. 8-fevral 2013-yilda asl nusxadan arxivlandi. Qaraldi: 2007-yil 15-avgust.
Gilead Sciences (2010-yil 20-dekabr). „Gilead Sciences to Acquire Arresto Biosciences for $225 Million; Deal Adds Pipeline Candidates for Fibrotic Diseases“. Press-reliz. 13-yanvar 2011-yilda asl nusxadan arxivlandi. Qaraldi: 2011-yil 15-yanvar.
(2011-yil 22-fevral). „Gilead Sciences to Acquire Calistoga Pharmaceuticals for $375 Million“. Press-reliz. Qaraldi: 2020-yil 12-iyul.
„Gilead Sciences to Acquire Immunomedics“.
„Gilead Statement on Zydelig® U.S. Indication for Follicular Lymphoma and Small Lymphocytic Leukemia“ (en). www.gilead.com. Qaraldi: 2022-yil 7-fevral.
„Mission & Core Values – Gilead“. www.gilead.com. 2022-yil 11-avgustda asl nusxadan arxivlangan. Qaraldi: 2022-yil 11-avgust.

investors.gilead.com

(unspecified title)
Gilead Sciences (2011-yil 22-fevral). „Gilead Sciences to Acquire Calistoga Pharmaceuticals for $375 Million; Deal Adds Pipeline Candidates in Oncology and Inflammation“. Press-reliz. 9-iyul 2012-yilda asl nusxadan arxivlandi. Qaraldi: 2011-yil 22-fevral.
„Gilead Sciences Announces Acquisition of Nimbus Therapeutics' Acetyl-CoA Carboxylase (ACC) Program for NASH and Other Liver Diseases | Gilead Sciences“. investors.gilead.com. 2021-yil 23-sentyabrda asl nusxadan arxivlangan. Qaraldi: 2022-yil 11-avgust.
„Gilead Completes Acquisition of Forty Seven, Inc.“. Gilead Sciences. 2022-yil 25-aprelda asl nusxadan arxivlangan. Qaraldi: 2020-yil 11-aprel.
„Gilead Sciences, Inc. 2019 Annual Report (Form 10-K)“ (PDF). U.S. Securities and Exchange Commission. Gilead Sciences (2020-yil fevral). 2022-yil 13-martda asl nusxadan arxivlangan. Qaraldi: 2022-yil 11-avgust.

google.com

Elbe, Stephan. Pandemics, Pills, and Politics: Governing Global Health Security. Baltimore: Johns Hopkins University Press, 2018 — 57 bet. ISBN 9781421425580. 2022-yil 4-fevralda qaraldi.
Elbe, Stephan. Pandemics, Pills, and Politics: Governing Global Health Security. Baltimore: Johns Hopkins University Press, 2018 — 60 bet. ISBN 9781421425580. 2022-yil 4-fevralda qaraldi.

healio.com

„FDA approves first generic of Tamiflu for influenza A, B“. www.healio.com (2016-yil 4-avgust). Qaraldi: 2020-yil 3-aprel.

independent.co.uk

„Donald Rumsfeld makes $5m killing on bird flu drug“. The Independent (2006-yil 12-mart). Qaraldi: 2020-yil 2-avgust.

investors.com

Allison Gatlin. „Will Gilead's HIV Franchise Plan Be Dashed On TrumpCare?“. Investor's Business Daily. Investors Business Daily (2017-yil 6-aprel).

ktvq.com

„Donald Rumsfeld Fast Facts“. KTVQ (2019-yil 27-iyun). Qaraldi: 2020-yil 3-aprel.

latimes.com

Petersen. „Patients sue Gilead, saying drug company intentionally delayed safer HIV medicine“. Los Angeles Times (2018-yil 5-may). Qaraldi: 2019-yil 7-dekabr.
Petersen, Melody. „Patients sue Gilead, saying drug company intentionally delayed safer HIV medicine“. Los Angeles Times (2018-yil 9-may). Qaraldi: 2022-yil 11-mart.

articles.latimes.com

Gellene, Denise. „Gilead Sciences to Buy Triangle Pharmaceuticals“. Los Angeles Times (2002-yil 5-dekabr).

macrotrends.net

„Gilead Sciences Revenue 2006–2018“. www.macrotrends.net. Qaraldi: 2018-yil 1-noyabr.

msf.org

„No profiteering on COVID-19 drugs and vaccines, says MSF“. Médecins Sans Frontières (MSF) International.

msn.com

today.msnbc.msn.com

Perrone. „FDA approves first pill to help prevent HIV“. Today Health. NBC News. 2012-yil 16-iyulda asl nusxadan arxivlangan. Qaraldi: 2012-yil 16-iyul.

nbcnews.com

Fitzsimmons, Tim. „#BreakThePatent: How HIV activists are going after Gilead's PrEP patent“ (en). NBC News (2018-yil 19-iyul). Qaraldi: 2021-yil 19-sentyabr.
Ryan, Benjamin. „Pharma giant's policy change will devastate local HIV-prevention clinics' efforts“ (en). NBC News (2021-yil 7-iyul). Qaraldi: 2021-yil 23-sentyabr.

nih.gov

pubmed.ncbi.nlm.nih.gov

Masho, Saba Woldemichael; Wang, Cun-Lin; Nixon, Daniel E (December 2007). „Review of tenofovir-emtricitabine“. Therapeutics and Clinical Risk Management. 3-jild, № 6. 1097–1104-bet. ISSN 1176-6336. PMC 2387297. PMID 18516268.
„Ledipasvir/Sofosbuvir: a review of its use in chronic hepatitis C“. Drugs. 75-jild, № 6. 2015. 675–85-bet. doi:10.1007/s40265-015-0381-2. PMID 25837989.
Tourret, Jérôme; Deray, Gilbert; Isnard-Bagnis, Corinne (2013). „Tenofovir Effect on the Kidneys of HIV-Infected Patients: A Double-Edged Sword?“. Journal of the American Society of Nephrology. 24-jild, № 10. 1519–1527-bet. doi:10.1681/ASN.2012080857. PMC 3785270. PMID 24052632.
Grigsby, Iwen F.; Pham, Lan; Mansky, Louis M.; Gopalakrishnan, Raj; Mansky, Kim C. (2010). „Tenofovir-associated bone density loss“. Therapeutics and Clinical Risk Management. 6-jild. 41–47-bet. PMC 2817787. PMID 20169035.
Walensky, Rochelle P.; Horn, Tim; McCann, Nicole C.; Freedberg, Kenneth A.; Paltiel, A. David (May 5, 2020). „Comparative Pricing of Branded Tenofovir Alafenamide–Emtricitabine Relative to Generic Tenofovir Disoproxil Fumarate–Emtricitabine for HIV Preexposure Prophylaxis: A Cost-Effectiveness Analysis“. Annals of Internal Medicine. 172-jild, № 9. 583–590-bet. doi:10.7326/m19-3478. PMC 7217721. PMID 32150602.
Rizk, John G.; Forthal, Donald N.; Kalantar-Zadeh, Kamyar; Mehra, Mandeep R.; Lavie, Carl J.; Rizk, Youssef; Pfeiffer, JoAnn P.; Lewin, John C. (2021). „Expanded Access Programs, compassionate drug use, and Emergency Use Authorizations during the COVID-19 pandemic“. Drug Discovery Today. 26-jild, № 2. 593–603-bet. doi:10.1016/j.drudis.2020.11.025. ISSN 1359-6446. PMC 7694556. PMID 33253920.
„A living WHO guideline on drugs for covid-19“. BMJ. 370-jild. September 2020. m3379-bet. doi:10.1136/bmj.m3379. PMID 32887691.
„Remdesivir for the treatment of patients in hospital with COVID-19 in Canada: a randomized controlled trial“. Canadian Medical Association Journal. 194-jild, № 7. January 2022. E242–E251-bet. doi:10.1503/cmaj.211698. PMC 8863204. PMID 35045989.

ncbi.nlm.nih.gov

Masho, Saba Woldemichael; Wang, Cun-Lin; Nixon, Daniel E (December 2007). „Review of tenofovir-emtricitabine“. Therapeutics and Clinical Risk Management. 3-jild, № 6. 1097–1104-bet. ISSN 1176-6336. PMC 2387297. PMID 18516268.
Tourret, Jérôme; Deray, Gilbert; Isnard-Bagnis, Corinne (2013). „Tenofovir Effect on the Kidneys of HIV-Infected Patients: A Double-Edged Sword?“. Journal of the American Society of Nephrology. 24-jild, № 10. 1519–1527-bet. doi:10.1681/ASN.2012080857. PMC 3785270. PMID 24052632.
Grigsby, Iwen F.; Pham, Lan; Mansky, Louis M.; Gopalakrishnan, Raj; Mansky, Kim C. (2010). „Tenofovir-associated bone density loss“. Therapeutics and Clinical Risk Management. 6-jild. 41–47-bet. PMC 2817787. PMID 20169035.
Walensky, Rochelle P.; Horn, Tim; McCann, Nicole C.; Freedberg, Kenneth A.; Paltiel, A. David (May 5, 2020). „Comparative Pricing of Branded Tenofovir Alafenamide–Emtricitabine Relative to Generic Tenofovir Disoproxil Fumarate–Emtricitabine for HIV Preexposure Prophylaxis: A Cost-Effectiveness Analysis“. Annals of Internal Medicine. 172-jild, № 9. 583–590-bet. doi:10.7326/m19-3478. PMC 7217721. PMID 32150602.
Rizk, John G.; Forthal, Donald N.; Kalantar-Zadeh, Kamyar; Mehra, Mandeep R.; Lavie, Carl J.; Rizk, Youssef; Pfeiffer, JoAnn P.; Lewin, John C. (2021). „Expanded Access Programs, compassionate drug use, and Emergency Use Authorizations during the COVID-19 pandemic“. Drug Discovery Today. 26-jild, № 2. 593–603-bet. doi:10.1016/j.drudis.2020.11.025. ISSN 1359-6446. PMC 7694556. PMID 33253920.
„Remdesivir for the treatment of patients in hospital with COVID-19 in Canada: a randomized controlled trial“. Canadian Medical Association Journal. 194-jild, № 7. January 2022. E242–E251-bet. doi:10.1503/cmaj.211698. PMC 8863204. PMID 35045989.

nih.gov

„Harold E. Varmus, M.D.“. National Institutes of Health (NIH) (2015-yil 6-avgust). Qaraldi: 2019-yil 25-fevral.

aidsinfo.nih.gov

(2012-yil 16-iyul). „FDA approves first drug for reducing the risk of sexually acquired HIV infection“. Press-reliz. 29-yanvar 2022-yilda asl nusxadan arxivlandi. Qaraldi: 2020-yil 12-iyul.

nobelprize.org

„The Nobel Prize in Physiology or Medicine 2009“. NobelPrize.org. Qaraldi: 2019-yil 25-fevral.

npr.org

Simmons-Duffin, Selena. „AIDS Activists Take Aim At Gilead To Lower Price Of HIV Drug PrEP“ (en). NPR (2019-yil 30-may). Qaraldi: 2021-yil 19-sentyabr.
Lupkin, Sydney. „FDA Grants Experimental Coronavirus Drug Benefits For Rare Disease Treatments“. NPR (2020-yil 24-mart). Qaraldi: 2020-yil 24-mart.

nytimes.com

Fisher, Lawrence M.. „F.D.A. Approves Gilead's Drug for AIDS Patients“ (en-US). The New York Times (1996-yil 28-iyun). Qaraldi: 2021-yil 22-sentyabr.
Pollack, Andrew. „F.D.A. Backs AIDS Pill to Be Taken Once a Day“. The New York Times (2006-yil 13-iyul). Qaraldi: 2007-yil 20-sentyabr.
„Gilead to Buy CV Therapeutics for $1.4 Billion“. The New York Times. Reuters (2009-yil 12-mart). Qaraldi: 2020-yil 25-aprel.
McNeil, Jr., Donald G.. „Gilead Will Donate Truvada to U.S. for H.I.V. Prevention“. The New York Times (2019-yil 9-may). Qaraldi: 2019-yil 4-dekabr.
McNeil, Jr., Donald G.. „200,000 Uninsured Americans to Get Free H.I.V.-Prevention Drugs“. The New York Times (2019-yil 3-dekabr). Qaraldi: 2019-yil 4-dekabr.
Sanger-Katz, Margot. „Critics Raise Concerns About Sovaldi“. The New York Times (2014-yil 2-avgust). Qaraldi: 2015-yil 4-oktyabr.
McNeil, Donald G.. „Gilead Will Donate Truvada to U.S. for H.I.V. Prevention“. The New York Times (2019-yil 10-may). Qaraldi: 2021-yil 20-sentyabr.

outsourcing-pharma.com

Stanton, Dan. „Gilead's reliance on CMOs gives firm 'flexibility' says CFO“. Outsourcing-Pharma.com. Crawley: William Reed Business Media Ltd (2015-yil 20-may). Qaraldi: 2020-yil 1-aprel.

parentherald.com

„Gilead Sciences: Nimbus Drug Acquired, Offering Cure For Fatty Liver“. Parent Herald (2016-yil 6-aprel).

pharmatimes.com

„Roche settles dispute with Gilead over Tamiflu“ (en). PharmaTimes (2005-yil 17-noyabr). Qaraldi: 2021-yil 19-sentyabr.

policymed.com

Sullivan, Thomas. „Senate Finance Committee Releases Results of Investigation Into Gilead's Pricing Strategy for Hepatitis-C Drugs“. Policy & Medicine (2018-yil 5-may).

reuters.com

„Gilead to buy Kite for promising cancer therapies in $12 billion deal“. reuters.com (2017-yil 28-avgust).
„Gilead buys Forty Seven for $4.9 billion to bolster cancer drug pipeline“. Reuters (2020-yil 2-mart).
„Gilead to buy 49.9% stake in cancer drug developer for $275 million“ (2020-yil 23-iyun).
„Gilead to acquire German biotech firm MYR for about 1.15 billion euros“. Reuters (2020-yil 10-dekabr).
Beasley, Deena. „Will Gilead price its coronavirus drug for public good or company profit?“ (en). Reuters (2020-yil 6-may). Qaraldi: 2021-yil 19-sentyabr. „Public outrage over the cost of Sovaldi in 2013 - despite that it was a vast improvement over existing equally expensive therapies - ignited a national debate on fair pricing for prescription medicines that the pharmaceutical industry has fought to deflect ever since.“.
Rapaport, Lisa. „New brand-name HIV-prevention pill not worth the added cost: study“ (en). Reuters (2020-yil 9-mart). Qaraldi: 2021-yil 23-sentyabr.

scribd.com

„Gilead Sciences Board Resolution Michael Riordan Founder CEO Chairman Antiviral Medicine AIDS Therapeutics Nucleotides“. Scribd. Qaraldi: 2017-yil 14-dekabr.

sec.gov

seekingalpha.com

„Gilead Q4 2014 Earnings Call“.
Ioannis Stamatopoulos. „Pharma M&A In 2017: The Most Likely Deal Hunters“. Seeking Alpha (2017-yil 12-fevral). Qaraldi: 2017-yil 12-mart.
Dulan Lokuwithana. „Gilead lifts 2021 guidance as remdesivir sales more than double in Q3“. Seeking Alpha (2021-yil 28-oktyabr). Qaraldi: 2022-yil 25-yanvar.

sfgate.com

Tansey, Bernadette. „Profile: Gilead Sciences / Gilead grows up / Visionary biotech startup matures into pragmatic industry leader“. San Francisco Chronicle. Hearst Communications, Inc. (2003-yil 14-aprel), s. E1. Qaraldi: 2020-yil 21-mart.

smh.com.au

Hammond. „A new pharma king? AstraZeneca approaches Gilead about potential merger: report“. The Sydney Morning Herald (2020-yil 7-iyun). Qaraldi: 2020-yil 8-iyun.

statnews.com

Silverman, Ed. „Gilead avoided nearly $10 billion in taxes last year thanks to tax dodges“ (en-US). Stat News (2016-yil 13-iyul). Qaraldi: 2022-yil 2-yanvar.

streetinsider.com

„Q4 Sovaldi Sales Tracking at $53 Million“. Street Insider (2014-yil 3-yanvar).

thepharmaletter.com

„Veklury becomes first option for COVID-19 approved in EU“. The Pharma Letter (2020-yil 7-mart). Qaraldi: 2022-yil 25-yanvar.

thetimes.co.uk

Paul O'Donoghue. „US pharma giant Gilead uses 'Double Irish' tax loophole“. The Times (2018-yil 26-dekabr).

washingtonpost.com

Rowland, Christopher. „An HIV treatment cost taxpayers millions. The government patented it. But a pharma giant is making billions.“. Washington Post (2019-yil 26-mart).
Stanley-Becker, Isaac. „Rand Paul discloses 16 months late that his wife bought stock in company behind covid treatment“ (en-US). The Washington Post (2021-yil 12-avgust). Qaraldi: 2021-yil 30-avgust.
Johnson, Carolyn Y.; Dennis, Brady. „How an $84,000 drug got its price: 'Let's hold our position … whatever the headlines'“. Washington Post (2015-yil 1-dekabr). Qaraldi: 2021-yil 19-sentyabr.
Rowland, Christopher. „Gilead CEO insists federal government patent for HIV prevention pill Truvada is invalid“. Washington Post (2019-yil 16-may). Qaraldi: 2021-yil 19-sentyabr.
Rowland, Christopher. „Gilead is accused of cutting anti-competitive deals to extend profit on HIV drug combinations“. Washington Post (2019-yil 14-may). Qaraldi: 2021-yil 27-sentyabr.
Merle, Renae; Johnson, Carolyn Y.. „The drug company that shocked the world with its prices dodged $10 billion in taxes, report says“ (en-US). Washington Post. Qaraldi: 2022-yil 2-yanvar.

web.archive.org

Stanton. „Activists pounce on $1,000-a-day price for Gilead's hep C wonder drug, Sovaldi“. FiercePharma. 2014-yil 18-fevralda asl nusxadan arxivlangan. Qaraldi: 2014-yil 22-fevral.
„1996 Alumni Achievement Awards“. Washington University in St. Louis. 2014-yil 21-avgustda asl nusxadan arxivlangan.
Gilead Sciences and Bristol-Myers Squibb (2006-yil 12-iyul). „U.S. Food And Drug Administration (FDA) Approves Atripla“. Press-reliz. 15-noyabr 2008-yilda asl nusxadan arxivlandi. Qaraldi: 2007-yil 15-dekabr.
Gilead Sciences (2006-yil 3-noyabr). „Gilead Sciences Completes Acquisition of Raylo Chemicals Inc.“. Press-reliz. 16-yanvar 2013-yilda asl nusxadan arxivlandi. Qaraldi: 2007-yil 7-iyun.
Gilead Sciences (2007-yil 15-avgust). „Parion Sciences and Gilead Sciences Sign Agreement to Advance Drug Candidates for Pulmonary Disease“. Press-reliz. 8-fevral 2013-yilda asl nusxadan arxivlandi. Qaraldi: 2007-yil 15-avgust.
Gilead Sciences (2010-yil 20-dekabr). „Gilead Sciences to Acquire Arresto Biosciences for $225 Million; Deal Adds Pipeline Candidates for Fibrotic Diseases“. Press-reliz. 13-yanvar 2011-yilda asl nusxadan arxivlandi. Qaraldi: 2011-yil 15-yanvar.
Perrone. „FDA approves first pill to help prevent HIV“. Today Health. NBC News. 2012-yil 16-iyulda asl nusxadan arxivlangan. Qaraldi: 2012-yil 16-iyul.
(2012-yil 16-iyul). „FDA approves first drug for reducing the risk of sexually acquired HIV infection“. Press-reliz. 29-yanvar 2022-yilda asl nusxadan arxivlandi. Qaraldi: 2020-yil 12-iyul.
„Gilead Sciences Announces Acquisition of Nimbus Therapeutics' Acetyl-CoA Carboxylase (ACC) Program for NASH and Other Liver Diseases | Gilead Sciences“. investors.gilead.com. 2021-yil 23-sentyabrda asl nusxadan arxivlangan. Qaraldi: 2022-yil 11-avgust.
„Gilead Completes Acquisition of Forty Seven, Inc.“. Gilead Sciences. 2022-yil 25-aprelda asl nusxadan arxivlangan. Qaraldi: 2020-yil 11-aprel.
„Gilead Sciences, Inc. 2019 Annual Report (Form 10-K)“ (PDF). U.S. Securities and Exchange Commission. Gilead Sciences (2020-yil fevral). 2022-yil 13-martda asl nusxadan arxivlangan. Qaraldi: 2022-yil 11-avgust.
„Mission & Core Values – Gilead“. www.gilead.com. 2022-yil 11-avgustda asl nusxadan arxivlangan. Qaraldi: 2022-yil 11-avgust.
Waldman. „Gilead's HCV drug sofosbuvir approved by the FDA but accessible for how many?“. Doctors of the World. 2014-yil 26-fevralda asl nusxadan arxivlangan. Qaraldi: 2014-yil 22-fevral.

worldcat.org

Masho, Saba Woldemichael; Wang, Cun-Lin; Nixon, Daniel E (December 2007). „Review of tenofovir-emtricitabine“. Therapeutics and Clinical Risk Management. 3-jild, № 6. 1097–1104-bet. ISSN 1176-6336. PMC 2387297. PMID 18516268.
Rizk, John G.; Forthal, Donald N.; Kalantar-Zadeh, Kamyar; Mehra, Mandeep R.; Lavie, Carl J.; Rizk, Youssef; Pfeiffer, JoAnn P.; Lewin, John C. (2021). „Expanded Access Programs, compassionate drug use, and Emergency Use Authorizations during the COVID-19 pandemic“. Drug Discovery Today. 26-jild, № 2. 593–603-bet. doi:10.1016/j.drudis.2020.11.025. ISSN 1359-6446. PMC 7694556. PMID 33253920.

wsj.com

Silverman, Ed. „Lawsuit Alleges Price Gouging by Maker of Hepatitis Drug“. Wall Street Journal (2014-yil 19-dekabr). Qaraldi: 2021-yil 19-sentyabr.
Silverman, Ed. „Gilead Deal to Sell Sovaldi in Poor Countries Meets Criticism“. Wall Street Journal (2014-yil 15-sentyabr). Qaraldi: 2021-yil 19-sentyabr.
„Gilead to Pay $464 Million For Triangle Pharmaceuticals“. Wall Street Journal (2002-yil 4-dekabr).
Lombardo, Cara; Rockoff, Jonathan D.. „Gilead Reaches Deal to Buy Immunomedics for $21 Billion“. Wall Street Journal (2020-yil 13-sentyabr). Qaraldi: 2020-yil 13-sentyabr.

wustl.edu

engineering.wustl.edu

„1996 Alumni Achievement Awards“. Washington University in St. Louis. 2014-yil 21-avgustda asl nusxadan arxivlangan.

yahoo.com

finance.yahoo.com

„Gilead (GILD) Collaborates with Galapagos for Filgotinib“. Yahoo Finance. Yahoo/Zack's. Qaraldi: 2015-yil 31-dekabr.